Clinical Trial Update: Psilocybin-Assisted Therapy in Treatment-Resistant Depression [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating psilocybin-assisted therapy for treatment-resistant depression is currently recruiting at the University of North Carolina, Chapel Hill…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Refractory Depression, Treatment Resistant Depression | Phase 3 | Status: RECRUITING